These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 1494904

  • 1. Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis.
    Jellinger K, Kienzl E, Rumpelmair G, Riederer P, Stachelberger H, Ben-Shachar D, Youdim MB.
    J Neurochem; 1992 Sep; 59(3):1168-71. PubMed ID: 1494904
    [Abstract] [Full Text] [Related]

  • 2. The role of transition metals in the pathogenesis of Parkinson's disease.
    Kienzl E, Puchinger L, Jellinger K, Linert W, Stachelberger H, Jameson RF.
    J Neurol Sci; 1995 Dec; 134 Suppl():69-78. PubMed ID: 8847547
    [Abstract] [Full Text] [Related]

  • 3. Iron as catalyst for oxidative stress in the pathogenesis of Parkinson's disease?
    Kienzl E, Jellinger K, Stachelberger H, Linert W.
    Life Sci; 1999 Dec; 65(18-19):1973-6. PubMed ID: 10576448
    [Abstract] [Full Text] [Related]

  • 4. Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry.
    Biesemeier A, Eibl O, Eswara S, Audinot JN, Wirtz T, Pezzoli G, Zucca FA, Zecca L, Schraermeyer U.
    J Neurochem; 2016 Jul; 138(2):339-53. PubMed ID: 27121280
    [Abstract] [Full Text] [Related]

  • 5. The role of iron in senescence of dopaminergic neurons in Parkinson's disease.
    Youdim MB, Riederer P.
    J Neural Transm Suppl; 1993 Jul; 40():57-67. PubMed ID: 8294901
    [Abstract] [Full Text] [Related]

  • 6. Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.
    Hirsch EC, Brandel JP, Galle P, Javoy-Agid F, Agid Y.
    J Neurochem; 1991 Feb; 56(2):446-51. PubMed ID: 1988548
    [Abstract] [Full Text] [Related]

  • 7. Iron, melanin and dopamine interaction: relevance to Parkinson's disease.
    Ben-Shachar D, Youdim MB.
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Jan; 17(1):139-50. PubMed ID: 8416600
    [Abstract] [Full Text] [Related]

  • 8. Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: an electron paramagnetic resonance spectroscopy study.
    Shima T, Sarna T, Swartz HM, Stroppolo A, Gerbasi R, Zecca L.
    Free Radic Biol Med; 1997 Jan; 23(1):110-9. PubMed ID: 9165303
    [Abstract] [Full Text] [Related]

  • 9. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study.
    Good PF, Olanow CW, Perl DP.
    Brain Res; 1992 Oct 16; 593(2):343-6. PubMed ID: 1450944
    [Abstract] [Full Text] [Related]

  • 10. Increased iron in the substantia nigra compacta of the MPTP-lesioned hemiparkinsonian African green monkey: evidence from proton microprobe elemental microanalysis.
    Temlett JA, Landsberg JP, Watt F, Grime GW.
    J Neurochem; 1994 Jan 16; 62(1):134-46. PubMed ID: 8263513
    [Abstract] [Full Text] [Related]

  • 11. The enigma of neuromelanin in Parkinson's disease substantia nigra.
    Youdim MB, Ben-Shachar D, Riederer P.
    J Neural Transm Suppl; 1994 Jan 16; 43():113-22. PubMed ID: 7884393
    [Abstract] [Full Text] [Related]

  • 12. Combined enrichment of neuromelanin granules and synaptosomes from human substantia nigra pars compacta tissue for proteomic analysis.
    Plum S, Helling S, Theiss C, Leite REP, May C, Jacob-Filho W, Eisenacher M, Kuhlmann K, Meyer HE, Riederer P, Grinberg LT, Gerlach M, Marcus K.
    J Proteomics; 2013 Dec 06; 94():202-206. PubMed ID: 23917253
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Magnetic resonance correlation of iron content with neuromelanin in the substantia nigra of early-stage Parkinson's disease.
    Reimão S, Ferreira S, Nunes RG, Pita Lobo P, Neutel D, Abreu D, Gonçalves N, Campos J, Ferreira JJ.
    Eur J Neurol; 2016 Feb 06; 23(2):368-74. PubMed ID: 26518135
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?
    Youdim MB, Ben-Shachar D, Riederer P.
    Acta Neurol Scand Suppl; 1989 Feb 06; 126():47-54. PubMed ID: 2618593
    [Abstract] [Full Text] [Related]

  • 17. Selectivity of melaninized nigra-striatal dopamine neurons to degeneration in Parkinson's disease may depend on iron-melanin interaction.
    Ben-Shachar D, Youdim MB.
    J Neural Transm Suppl; 1990 Feb 06; 29():251-8. PubMed ID: 2193109
    [Abstract] [Full Text] [Related]

  • 18. Melanin and Neuromelanin: Linking Skin Pigmentation and Parkinson's Disease.
    Krainc T, Monje MHG, Kinsinger M, Bustos BI, Lubbe SJ.
    Mov Disord; 2023 Feb 06; 38(2):185-195. PubMed ID: 36350228
    [Abstract] [Full Text] [Related]

  • 19. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL.
    Brain; 2005 Nov 06; 128(Pt 11):2654-64. PubMed ID: 16000336
    [Abstract] [Full Text] [Related]

  • 20. Correlation between pathology and neuromelanin MR imaging in Parkinson's disease and dementia with Lewy bodies.
    Kitao S, Matsusue E, Fujii S, Miyoshi F, Kaminou T, Kato S, Ito H, Ogawa T.
    Neuroradiology; 2013 Aug 06; 55(8):947-953. PubMed ID: 23673875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.